ARHGEF1: Difference between revisions
Hmainsbot1 (talk | contribs) m →Interactions: AWB general fixes and, delink dates per WP:DATELINK, WP:YEARLINK and MOS:UNLINKYEARS using AWB (8097) |
m →Function: +wl |
||
(23 intermediate revisions by 16 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Protein-coding gene in the species Homo sapiens}} |
|||
{{PBB|geneid=9138}} |
|||
{{cs1 config|name-list-style=vanc|display-authors=6}} |
|||
⚫ | '''Rho guanine nucleotide exchange factor 1''' is a [[protein]] that in humans is encoded by the ''ARHGEF1'' [[gene]].<ref name="pmid8810315">{{cite journal | |
||
{{Infobox_gene}} |
|||
⚫ | '''Rho guanine nucleotide exchange factor 1''' is a [[protein]] that in humans is encoded by the ''ARHGEF1'' [[gene]].<ref name="pmid8810315">{{cite journal | vauthors = Hart MJ, Sharma S, elMasry N, Qiu RG, McCabe P, Polakis P, Bollag G | title = Identification of a novel guanine nucleotide exchange factor for the Rho GTPase | journal = The Journal of Biological Chemistry | volume = 271 | issue = 41 | pages = 25452–8 | date = October 1996 | pmid = 8810315 | doi = 10.1074/jbc.271.41.25452 | doi-access = free }}</ref><ref name="pmid9135076">{{cite journal | vauthors = Aasheim HC, Pedeutour F, Smeland EB | title = Characterization, expression and chromosomal localization of a human gene homologous to the mouse Lsc oncogene, with strongest expression in hematopoetic tissues | journal = Oncogene | volume = 14 | issue = 14 | pages = 1747–52 | date = April 1997 | pmid = 9135076 | doi = 10.1038/sj.onc.1200994 | s2cid = 24528606 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: ARHGEF1 Rho guanine nucleotide exchange factor (GEF) 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=9138}}</ref> This protein is also called RhoGEF1 or p115-RhoGEF. |
||
== Function == |
|||
Rho guanine nucleotide exchange factor 1 is [[guanine nucleotide exchange factor]] (GEF) for the [[RhoA]] [[small GTPase]] protein.<ref name="pmid8810315">{{cite journal | vauthors = Hart MJ, Sharma S, elMasry N, Qiu RG, McCabe P, Polakis P, Bollag G | title = Identification of a novel guanine nucleotide exchange factor for the Rho GTPase | journal = The Journal of Biological Chemistry | volume = 271 | issue = 41 | pages = 25452–8 | date = October 1996 | pmid = 8810315 | doi = 10.1074/jbc.271.41.25452 | doi-access = free }}</ref> Rho is a [[small GTPase]] protein that is inactive when bound to the [[guanine]] [[nucleotide]] [[guanosine diphosphate|GDP]]. But when acted on by Rho GEF proteins such as RhoGEF1, this GDP is released and replaced by [[guanosine triphosphate|GTP]], leading to the active state of Rho. In this active, GTP-bound conformation, Rho can bind to and activate specific [[effector (biology)|effector]] proteins and [[enzymes]] to regulate cellular functions.<ref name="pmid24183240">{{cite journal | vauthors = Thumkeo D, Watanabe S, Narumiya S | title = Physiological roles of Rho and Rho effectors in mammals | journal = European Journal of Cell Biology | volume = 92 | issue = 10–11 | pages = 303–15 | date = Oct–Nov 2013 | pmid = 24183240 | doi = 10.1016/j.ejcb.2013.09.002 }} |
|||
</ref> In particular, active Rho is a major regulator of the cell [[actin]] [[cytoskeleton]].<ref name="pmid24183240"/> |
|||
RhoGEF1 is a member of a group of four [[RhoGEF]] proteins known to be activated by [[G protein coupled receptors]] coupled to the [[G12/G13 alpha subunits|G<sub>12</sub> and G<sub>13</sub>]] [[heterotrimeric G protein]]s.<ref name=pmid9641915>{{cite journal | vauthors = Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, Bollag G, Sternweis PC | title = p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13 | journal = Science | volume = 280 | issue = 5372 | pages = 2109–11 | date = June 1998 | pmid = 9641915 | doi = 10.1126/science.280.5372.2109 }}</ref><ref name=pmid9641916>{{cite journal | vauthors = Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, Bollag G | title = Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13 | journal = Science | volume = 280 | issue = 5372 | pages = 2112–4 | date = June 1998 | pmid = 9641916 | doi = 10.1126/science.280.5372.2112 }}</ref> The others are [[ARHGEF11]] (also known as PDZ-RhoGEF), [[ARHGEF12]] (also known as LARG) and [[AKAP13]] (also known as ARHGEF13 and Lbc). <ref name = pmid11313914>{{cite journal | vauthors = Fukuhara S, Chikumi H, Gutkind JS | title = RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho? | journal = Oncogene | volume = 20 | issue = 13 | pages = 1661–8 | date = March 2001 | pmid = 11313914 | doi = 10.1038/sj.onc.1204182 | doi-access = free }}</ref><ref name="pmid11546812">{{cite journal | vauthors = Diviani D, Soderling J, Scott JD | title = AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress fiber formation | journal = The Journal of Biological Chemistry | volume = 276 | issue = 47 | pages = 44247–57 | date = November 2001 | pmid = 11546812 | doi = 10.1074/jbc.M106629200 | doi-access = free }}</ref> GPCR-regulated RhoGEF1 (and these related GEF proteins) acts as an effector for G<sub>12</sub> and G<sub>13</sub> G proteins. In addition to being activated by G<sub>12</sub> or G<sub>13</sub> G proteins, three of these four RhoGEF proteins (ARHGEF1/11/12) also function as [[Regulator of G protein signaling|RGS family]] [[GTPase-activating proteins|GTPase-activating proteins (GAPs)]] to increase the rate of GTP hydrolysis of G<sub>12</sub>/G<sub>13</sub> alpha proteins (which are themselves GTPase proteins). This action increases the rate of G protein deactivation, limiting the time during which these RhoGEFs activate Rho.<ref name="pmid11358341">{{cite journal | vauthors = Kozasa T | title = Regulation of G protein-mediated signal transduction by RGS proteins | journal = Life Sciences | volume = 68 | issue = 19–20 | pages = 2309–17 | date = April 2001 | pmid = 11358341 | doi = 10.1016/S0024-3205(01)01020-7 }}</ref> |
|||
{{PBB_Summary |
|||
| section_title = |
|||
| summary_text = Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein may form a complex with G proteins and stimulate Rho-dependent signals. Multiple alternatively spliced transcript variants have been found for this gene, but the full-length nature of some variants has not been defined.<ref name="entrez" /> |
|||
}} |
|||
Multiple alternatively spliced transcript variants have been identified for this gene, but the full-length nature and function of some variants has not been defined.<ref name="entrez"/> |
|||
==Interactions== |
|||
ARHGEF1 has been shown to [[Protein-protein_interaction|interact]] with [[GNA13]],<ref name=pmid14634662><div class='references-small'> </div> </ref><ref name=pmid12681510>{{cite journal |last=Bhattacharyya |first=Raja |authorlink= |coauthors=Wedegaertner Philip B |year=2003|month=Apr. |title=Mutation of an N-terminal acidic-rich region of p115-RhoGEF dissociates alpha13 binding and alpha13-promoted plasma membrane recruitment |journal=FEBS Lett. |volume=540 |issue=1–3 |pages=211–6 |publisher= |location = Netherlands| issn = 0014-5793| pmid = 12681510 |doi=10.1016/S0014-5793(03)00267-9 }}</ref><ref name=pmid9641916>{{cite journal |last=Hart |first=M J |authorlink= |coauthors=Jiang X, Kozasa T, Roscoe W, Singer W D, Gilman A G, Sternweis P C, Bollag G |year=1998|month=Jun. |title=Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13 |journal=[[Science (journal)|Science]] |volume=280 |issue=5372 |pages=2112–4 |publisher= |location = UNITED STATES| issn = 0036-8075| pmid = 9641916 |doi=10.1126/science.280.5372.2112 }}</ref> [[CD44]],<ref name="pmid14634662" /> [[P110α]]<ref name=pmid12754211>{{cite journal |last=Holinstat |first=Michael |authorlink= |coauthors=Mehta Dolly, Kozasa Tohru, Minshall Richard D, Malik Asrar B |year=2003|month=Aug. |title=Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement |journal=J. Biol. Chem. |volume=278 |issue=31 |pages=28793–8 |publisher= |location = United States| issn = 0021-9258| pmid = 12754211 |doi = 10.1074/jbc.M303900200 }}</ref> and [[GNA12]].<ref name=pmid14634662/> |
|||
== |
== Interactions == |
||
ARHGEF1 has been shown to [[Protein-protein interaction|interact]] with: |
|||
* [[CD44]]<ref name = "pmid14634662">{{cite journal | vauthors = Johnson EN, Seasholtz TM, Waheed AA, Kreutz B, Suzuki N, Kozasa T, Jones TL, Brown JH, Druey KM | title = RGS16 inhibits signalling through the G alpha 13-Rho axis | journal = Nature Cell Biology | volume = 5 | issue = 12 | pages = 1095–103 | date = December 2003 | pmid = 14634662 | doi = 10.1038/ncb1065 | s2cid = 6798899 | url = https://zenodo.org/record/1233351 }}</ref> |
|||
* [[GNA12]]<ref name = pmid14634662/> |
|||
* [[GNA13]]<ref name = pmid9641916/> |
|||
⚫ | * [[P110α]]<ref name = pmid12754211>{{cite journal | vauthors = Holinstat M, Mehta D, Kozasa T, Minshall RD, Malik AB | title = Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement | journal = The Journal of Biological Chemistry | volume = 278 | issue = 31 | pages = 28793–8 | date = August 2003 | pmid = 12754211 | doi = 10.1074/jbc.M303900200 | doi-access = free }}</ref> |
||
== See also == |
|||
* [[Second messenger system]] |
|||
* [[G protein-coupled receptor]] |
|||
* [[Heterotrimeric G protein]] |
|||
* [[Small GTPases]] |
|||
* [[Rho family of GTPases]] |
|||
== References == |
|||
{{reflist}} |
{{reflist}} |
||
{{Clear}} |
|||
⚫ | |||
== External links == |
|||
* {{UCSC gene info|ARHGEF1}} |
|||
⚫ | |||
{{refbegin | 2}} |
{{refbegin | 2}} |
||
* {{cite journal | vauthors = Bhattacharyya R, Wedegaertner PB | title = Galpha 13 requires palmitoylation for plasma membrane localization, Rho-dependent signaling, and promotion of p115-RhoGEF membrane binding | journal = The Journal of Biological Chemistry | volume = 275 | issue = 20 | pages = 14992–9 | date = May 2000 | pmid = 10747909 | doi = 10.1074/jbc.M000415200 | doi-access = free }} |
|||
{{PBB_Further_reading |
|||
⚫ | * {{cite journal | vauthors = Wells CD, Gutowski S, Bollag G, Sternweis PC | title = Identification of potential mechanisms for regulation of p115 RhoGEF through analysis of endogenous and mutant forms of the exchange factor | journal = The Journal of Biological Chemistry | volume = 276 | issue = 31 | pages = 28897–905 | date = August 2001 | pmid = 11384980 | doi = 10.1074/jbc.M102913200 | doi-access = free }} |
||
| citations = |
|||
*{{cite journal |
* {{cite journal | vauthors = Chen Z, Wells CD, Sternweis PC, Sprang SR | title = Structure of the rgRGS domain of p115RhoGEF | journal = Nature Structural Biology | volume = 8 | issue = 9 | pages = 805–9 | date = September 2001 | pmid = 11524686 | doi = 10.1038/nsb0901-805 | s2cid = 11040143 }} |
||
⚫ | * {{cite journal | vauthors = Chen Z, Singer WD, Wells CD, Sprang SR, Sternweis PC | title = Mapping the Galpha13 binding interface of the rgRGS domain of p115RhoGEF | journal = The Journal of Biological Chemistry | volume = 278 | issue = 11 | pages = 9912–9 | date = March 2003 | pmid = 12525488 | doi = 10.1074/jbc.M212695200 | doi-access = free }} |
||
*{{cite journal | author=Kozasa T |title=p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13 |journal=Science |volume=280 |issue= 5372 |pages= 2109–11 |year= 1998 |pmid= 9641915 |doi=10.1126/science.280.5372.2109 | author-separator=, | author2=Jiang X | author3=Hart MJ | display-authors=3 | last4=Sternweis | first4=PM | last5=Singer | first5=WD | last6=Gilman | first6=AG | last7=Bollag | first7=G | last8=Sternweis | first8=PC }} |
|||
⚫ | * {{cite journal | vauthors = Bhattacharyya R, Wedegaertner PB | title = Characterization of G alpha 13-dependent plasma membrane recruitment of p115RhoGEF | journal = The Biochemical Journal | volume = 371 | issue = Pt 3 | pages = 709–20 | date = May 2003 | pmid = 12534370 | pmc = 1223324 | doi = 10.1042/BJ20021897 }} |
||
*{{cite journal | author=Hart MJ |title=Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13 |journal=Science |volume=280 |issue= 5372 |pages= 2112–4 |year= 1998 |pmid= 9641916 |doi=10.1126/science.280.5372.2112 | author-separator=, | author2=Jiang X | author3=Kozasa T | display-authors=3 | last4=Roscoe | first4=W | last5=Singer | first5=WD | last6=Gilman | first6=AG | last7=Sternweis | first7=PC | last8=Bollag | first8=G }} |
|||
⚫ | * {{cite journal | vauthors = Bhattacharyya R, Wedegaertner PB | title = Mutation of an N-terminal acidic-rich region of p115-RhoGEF dissociates alpha13 binding and alpha13-promoted plasma membrane recruitment | journal = FEBS Letters | volume = 540 | issue = 1–3 | pages = 211–6 | date = April 2003 | pmid = 12681510 | doi = 10.1016/S0014-5793(03)00267-9 | s2cid = 84132104 }} |
||
*{{cite journal | author=Zhang H |title=Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF |journal=Curr. Biol. |volume=9 |issue= 21 |pages= 1271–4 |year= 1999 |pmid= 10556093 |doi=10.1016/S0960-9822(99)80511-9 | author-separator=, | author2=Wang L | author3=Kao S | display-authors=3 | last4=Whitehead | first4=I.P. | last5=Hart | first5=M.J. | last6=Liu | first6=B. | last7=Duus | first7=K. | last8=Burridge | first8=K. | last9=Der | first9=C.J. }} |
|||
*{{cite journal |
* {{cite journal | vauthors = Bourguignon LY, Singleton PA, Zhu H, Diedrich F | title = Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression | journal = The Journal of Biological Chemistry | volume = 278 | issue = 32 | pages = 29420–34 | date = August 2003 | pmid = 12748184 | doi = 10.1074/jbc.M301885200 | doi-access = free }} |
||
*{{cite journal |
* {{cite journal | vauthors = Holinstat M, Mehta D, Kozasa T, Minshall RD, Malik AB | title = Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement | journal = The Journal of Biological Chemistry | volume = 278 | issue = 31 | pages = 28793–8 | date = August 2003 | pmid = 12754211 | doi = 10.1074/jbc.M303900200 | doi-access = free }} |
||
*{{cite journal | author=Kozasa T |title=Regulation of G protein-mediated signal transduction by RGS proteins |journal=Life Sci. |volume=68 |issue= 19–20 |pages= 2309–17 |year= 2001 |pmid= 11358341 |doi=10.1016/S0024-3205(01)01020-7 }} |
|||
⚫ | *{{cite journal |
||
*{{cite journal | author=Chen Z, Wells CD, Sternweis PC, Sprang SR |title=Structure of the rgRGS domain of p115RhoGEF |journal=Nat. Struct. Biol. |volume=8 |issue= 9 |pages= 805–9 |year= 2001 |pmid= 11524686 |doi= 10.1038/nsb0901-805 }} |
|||
*{{cite journal | author=Park B |title=Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation |journal=J. Biol. Chem. |volume=277 |issue= 47 |pages= 45361–70 |year= 2003 |pmid= 12270917 |doi= 10.1074/jbc.M202447200 | author-separator=, | author2=Nguyen NT | author3=Dutt P | display-authors=3 | last4=Merdek | first4=KD | last5=Bashar | first5=M | last6=Sterpetti | first6=P | last7=Tosolini | first7=A | last8=Testa | first8=JR | last9=Toksoz | first9=D }} |
|||
*{{cite journal | author=Driessens MH |title=B plexins activate Rho through PDZ-RhoGEF |journal=FEBS Lett. |volume=529 |issue= 2–3 |pages= 168–72 |year= 2002 |pmid= 12372594 |doi=10.1016/S0014-5793(02)03323-9 | author-separator=, | author2=Olivo C | author3=Nagata K | display-authors=3 | last4=Inagaki | first4=M | last5=Collard | first5=JG }} |
|||
*{{cite journal | author=Strausberg RL |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 | author-separator=, | author2=Feingold EA | author3=Grouse LH | display-authors=3 | last4=Derge | first4=JG | last5=Klausner | first5=RD | last6=Collins | first6=FS | last7=Wagner | first7=L | last8=Shenmen | first8=CM | last9=Schuler | first9=GD }} |
|||
⚫ | *{{cite journal |
||
⚫ | |||
⚫ | *{{cite journal |
||
*{{cite journal | author=Bourguignon LY, Singleton PA, Zhu H, Diedrich F |title=Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression |journal=J. Biol. Chem. |volume=278 |issue= 32 |pages= 29420–34 |year= 2003 |pmid= 12748184 |doi= 10.1074/jbc.M301885200 }} |
|||
⚫ | *{{cite journal |
||
}} |
|||
{{refend}} |
{{refend}} |
||
{{PDB Gallery|geneid=9138}} |
{{PDB Gallery|geneid=9138}} |
||
{{gene-19-stub}} |
{{gene-19-stub}} |
||
{{PBB_Controls |
|||
| update_page = yes |
|||
| require_manual_inspection = no |
|||
| update_protein_box = yes |
|||
| update_summary = yes |
|||
| update_citations = yes |
|||
}} |
Latest revision as of 19:08, 27 July 2024
Rho guanine nucleotide exchange factor 1 is a protein that in humans is encoded by the ARHGEF1 gene.[5][6][7] This protein is also called RhoGEF1 or p115-RhoGEF.
Function
[edit]Rho guanine nucleotide exchange factor 1 is guanine nucleotide exchange factor (GEF) for the RhoA small GTPase protein.[5] Rho is a small GTPase protein that is inactive when bound to the guanine nucleotide GDP. But when acted on by Rho GEF proteins such as RhoGEF1, this GDP is released and replaced by GTP, leading to the active state of Rho. In this active, GTP-bound conformation, Rho can bind to and activate specific effector proteins and enzymes to regulate cellular functions.[8] In particular, active Rho is a major regulator of the cell actin cytoskeleton.[8]
RhoGEF1 is a member of a group of four RhoGEF proteins known to be activated by G protein coupled receptors coupled to the G12 and G13 heterotrimeric G proteins.[9][10] The others are ARHGEF11 (also known as PDZ-RhoGEF), ARHGEF12 (also known as LARG) and AKAP13 (also known as ARHGEF13 and Lbc). [11][12] GPCR-regulated RhoGEF1 (and these related GEF proteins) acts as an effector for G12 and G13 G proteins. In addition to being activated by G12 or G13 G proteins, three of these four RhoGEF proteins (ARHGEF1/11/12) also function as RGS family GTPase-activating proteins (GAPs) to increase the rate of GTP hydrolysis of G12/G13 alpha proteins (which are themselves GTPase proteins). This action increases the rate of G protein deactivation, limiting the time during which these RhoGEFs activate Rho.[13]
Multiple alternatively spliced transcript variants have been identified for this gene, but the full-length nature and function of some variants has not been defined.[7]
Interactions
[edit]ARHGEF1 has been shown to interact with:
See also
[edit]- Second messenger system
- G protein-coupled receptor
- Heterotrimeric G protein
- Small GTPases
- Rho family of GTPases
References
[edit]- ^ a b c GRCh38: Ensembl release 89: ENSG00000076928 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000040940 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ a b Hart MJ, Sharma S, elMasry N, Qiu RG, McCabe P, Polakis P, et al. (October 1996). "Identification of a novel guanine nucleotide exchange factor for the Rho GTPase". The Journal of Biological Chemistry. 271 (41): 25452–8. doi:10.1074/jbc.271.41.25452. PMID 8810315.
- ^ Aasheim HC, Pedeutour F, Smeland EB (April 1997). "Characterization, expression and chromosomal localization of a human gene homologous to the mouse Lsc oncogene, with strongest expression in hematopoetic tissues". Oncogene. 14 (14): 1747–52. doi:10.1038/sj.onc.1200994. PMID 9135076. S2CID 24528606.
- ^ a b "Entrez Gene: ARHGEF1 Rho guanine nucleotide exchange factor (GEF) 1".
- ^ a b Thumkeo D, Watanabe S, Narumiya S (Oct–Nov 2013). "Physiological roles of Rho and Rho effectors in mammals". European Journal of Cell Biology. 92 (10–11): 303–15. doi:10.1016/j.ejcb.2013.09.002. PMID 24183240.
- ^ Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, et al. (June 1998). "p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13". Science. 280 (5372): 2109–11. doi:10.1126/science.280.5372.2109. PMID 9641915.
- ^ a b Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, et al. (June 1998). "Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13". Science. 280 (5372): 2112–4. doi:10.1126/science.280.5372.2112. PMID 9641916.
- ^ Fukuhara S, Chikumi H, Gutkind JS (March 2001). "RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho?". Oncogene. 20 (13): 1661–8. doi:10.1038/sj.onc.1204182. PMID 11313914.
- ^ Diviani D, Soderling J, Scott JD (November 2001). "AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress fiber formation". The Journal of Biological Chemistry. 276 (47): 44247–57. doi:10.1074/jbc.M106629200. PMID 11546812.
- ^ Kozasa T (April 2001). "Regulation of G protein-mediated signal transduction by RGS proteins". Life Sciences. 68 (19–20): 2309–17. doi:10.1016/S0024-3205(01)01020-7. PMID 11358341.
- ^ a b Johnson EN, Seasholtz TM, Waheed AA, Kreutz B, Suzuki N, Kozasa T, et al. (December 2003). "RGS16 inhibits signalling through the G alpha 13-Rho axis". Nature Cell Biology. 5 (12): 1095–103. doi:10.1038/ncb1065. PMID 14634662. S2CID 6798899.
- ^ Holinstat M, Mehta D, Kozasa T, Minshall RD, Malik AB (August 2003). "Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement". The Journal of Biological Chemistry. 278 (31): 28793–8. doi:10.1074/jbc.M303900200. PMID 12754211.
External links
[edit]- Human ARHGEF1 genome location and ARHGEF1 gene details page in the UCSC Genome Browser.
Further reading
[edit]- Bhattacharyya R, Wedegaertner PB (May 2000). "Galpha 13 requires palmitoylation for plasma membrane localization, Rho-dependent signaling, and promotion of p115-RhoGEF membrane binding". The Journal of Biological Chemistry. 275 (20): 14992–9. doi:10.1074/jbc.M000415200. PMID 10747909.
- Wells CD, Gutowski S, Bollag G, Sternweis PC (August 2001). "Identification of potential mechanisms for regulation of p115 RhoGEF through analysis of endogenous and mutant forms of the exchange factor". The Journal of Biological Chemistry. 276 (31): 28897–905. doi:10.1074/jbc.M102913200. PMID 11384980.
- Chen Z, Wells CD, Sternweis PC, Sprang SR (September 2001). "Structure of the rgRGS domain of p115RhoGEF". Nature Structural Biology. 8 (9): 805–9. doi:10.1038/nsb0901-805. PMID 11524686. S2CID 11040143.
- Chen Z, Singer WD, Wells CD, Sprang SR, Sternweis PC (March 2003). "Mapping the Galpha13 binding interface of the rgRGS domain of p115RhoGEF". The Journal of Biological Chemistry. 278 (11): 9912–9. doi:10.1074/jbc.M212695200. PMID 12525488.
- Bhattacharyya R, Wedegaertner PB (May 2003). "Characterization of G alpha 13-dependent plasma membrane recruitment of p115RhoGEF". The Biochemical Journal. 371 (Pt 3): 709–20. doi:10.1042/BJ20021897. PMC 1223324. PMID 12534370.
- Bhattacharyya R, Wedegaertner PB (April 2003). "Mutation of an N-terminal acidic-rich region of p115-RhoGEF dissociates alpha13 binding and alpha13-promoted plasma membrane recruitment". FEBS Letters. 540 (1–3): 211–6. doi:10.1016/S0014-5793(03)00267-9. PMID 12681510. S2CID 84132104.
- Bourguignon LY, Singleton PA, Zhu H, Diedrich F (August 2003). "Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression". The Journal of Biological Chemistry. 278 (32): 29420–34. doi:10.1074/jbc.M301885200. PMID 12748184.
- Holinstat M, Mehta D, Kozasa T, Minshall RD, Malik AB (August 2003). "Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement". The Journal of Biological Chemistry. 278 (31): 28793–8. doi:10.1074/jbc.M303900200. PMID 12754211.